Henry Ford Health cardiologists are the first to offer new Tri-Clip procedure to patients for whom open-heart surgery isn’t an option A breakthrough in treating tricuspid regurgitation, or TR, is ...
THE DEATH PENALTY. A RETIRED MOUNT AIRY NURSE MADE HISTORY AND IT INVOLVES HER HEART. SHE IS THE FIRST PERSON TO UNDERGO A NEW PROCEDURE HERE IN THE PIEDMONT. WXII 12 KRIS PETERSON HAS DETAILS ON THE ...
LONG BEACH, Calif., June 4, 2025 /PRNewswire/ -- The cardiology team at the MemorialCare Heart & Vascular Institute at Long Beach Medical Center, led by Chief of Cardiology David Shavelle, M.D., ...
A team of interventional cardiologists from Henry Ford Health's Center for Structural Heart Disease recently became the first in the United States and the Western Hemisphere to repair a heart valve ...
PARIS, France—Percutaneous edge-to-edge repair with a clip device appears to offer some hope for patients with tricuspid regurgitation, according to new results from the TRILUMINATE study. At 30 days, ...
LONDON, England—Results from several small and preliminary studies testing a range of devices for tricuspid regurgitation (TR) hint that percutaneous therapies are making progress for what’s long been ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window PARIS -- A ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window SAN FRANCISCO -- ...
Patients with leaking tricuspid valves in a research trial saw improvements with a procedure that does not require a risky open-heart surgery. By Gina Kolata For the first time, patients with damaged ...
(RTTNews) - Abbott (ABT) said that its TriClip Transcatheter Tricuspid Valve Repair System has received CE Mark and is now approved for use in Europe and other countries that recognize CE Mark as a ...
This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. The Centers for Medicare and Medicaid Services has agreed ...
The investigational transfemoral EVOQUE tricuspid valve replacement system (Edwards Lifesciences) significantly reduced severity of tricuspid regurgitation and improved quality of life at 30 days in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results